Compound ID | 530
MC 510051 (MF-EA-371 α)
Class: Efflux pump inhibitor (O-sulfates of benastatins A and B)
| Details of activity: | Permeates bacteria to other antibiotic compounds |
| Combined with other compounds: | Tested with Levofloxacin and results were positive |
| Institute where first reported: | Microcide Pharmaceuticals; (Essential Therapeutics (Ceased)); Daiichi Sankyo Pharmaceutical, Japan |
| Year first mentioned: | 2000 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.